Skip to main content
. 2014 Sep 21;20(35):12526–12532. doi: 10.3748/wjg.v20.i35.12526

Table 1.

Brief summary of necroptosis and necrostatin-1 effects in different liver disease models

Disease model Probable necroptosis inducer Downstream signaling Nec-1 effects Ref.
Ethanol induced liver injury TNF-α JNK acts downstream of RIP3 No effect [16]
Ethanol induced liver injury TNF-α No information No information [31]
APAP-induced liver toxicity Unknown JNK acts downstream of RIP3 Protective [17]
APAP-induced liver toxicity Unknown No information Protective [32]
APAP-induced liver toxicity Unknown JNK acts downstream of RIP1 Protective [15]
Con-A induced hepatitis model TRAIL PARP-1 acts downstream of RIP3 Protective [33]
Con-A-induced hepatitis Unknown No information Protective [34]
Liver sepsis model FasL No information Hepatotoxic [25]

APAP: Acetaminophen; Con-A: Concanavalin; TNF-α: Tumor necrosis factor-α; JNK: C-Jun N-terminal kinase; RIP3: Receptor-interacting serine-threonine kinase 3; TRAIL: TNF-related apoptosis-inducing ligand; Nec: Necrostatin.